HUNTSVILLE – Curiteva, pioneers of the world’s first 3D printed interbody spinal implants, has received limited commercial release of the product, the company announced.

The Huntsville-based technology and manufacturing company utilizes 3D-printed spinal implants for spine surgery. The implants are made using Curiteva’s recently FDA-cleared Inspire platform.

According to Todd Reith, vice president of Emerging Technology, the new technology further demonstrates Curiteva’s commitment to developing and investing in disruptive technologies.

“Our unique architecture is the result of years of research and development in 3D printing,” said Reith. “As this technology matures, with our internal expertise, we have already contemplated other applications outside of spine and orthopedics.”

The platform is manufactured using a high-performance polymer on a 3D printer designed, programmed, and built by Curiteva.

“I believe structure drives biology and the … architecture enabled by Curiteva’s 3D printing process represents an exciting advancement in spine, orthopedics, and neurosurgical procedures which involve any type of biologic implant,” said Dr. Alex Vaccaro, president of Philadelphia-based Rothman Orthopedic Institute.

Dr. Kevin Foley, chairman of Semmes-Murphey Neurologic and Spine Institute and professor of neurosurgery, orthopedic surgery and biomedical engineering at the University of Tennessee, said, “The Inspire porous PEEK technology checks all of the boxes for an ideal interbody implant: fully interconnected porosity, modulus of elasticity equivalent to cancellous bone, strong biomechanical properties, radiolucency, and a bioactive surface for osseointegration.”

Curiteva plans a full commercial launch in the United States this year.